Share on StockTwits
 

KYTHERA Biopharmaceuticals (NASDAQ:KYTH) CFO John W. Smither sold 1,125 shares of the stock on the open market in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $50.00, for a total transaction of $56,250.00. Following the transaction, the chief financial officer now directly owns 10,200 shares in the company, valued at approximately $510,000. The transaction was disclosed in a filing with the SEC, which is available at this link.

KYTHERA Biopharmaceuticals (NASDAQ:KYTH) traded down 0.31% during mid-day trading on Tuesday, hitting $48.26. The stock had a trading volume of 203,942 shares. KYTHERA Biopharmaceuticals has a 1-year low of $14.07 and a 1-year high of $50.98. The stock has a 50-day moving average of $42.64 and a 200-day moving average of $38.4. The company’s market cap is $1.033 billion.

KYTHERA Biopharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.